Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (42)

« Back to Publications

IL-1β promotes IL-17A production of ILC3s to aggravate neutrophilic airway inflammation in mice.

Yang D. et al, (2025), Immunology, 176, 16 - 32

IL-5 antagonism reverses priming and activation of eosinophils in severe eosinophilic asthma.

Luo J. et al, (2024), Mucosal immunology, 17, 524 - 536

Pre-existing asthma as a comorbidity does not modify cytokine responses and severity of COVID-19

Luo J. et al, (2024)

The use of high-flow nasal cannula in patients with chronic obstructive pulmonary disease under exacerbation and stable phases: A systematic review and meta-analysis.

Yang H. et al, (2023), Heart & lung : the journal of critical care, 60, 116 - 126

Group 3 innate lymphoid cells secret neutrophil chemoattractants and are insensitive to glucocorticoid via aberrant GR phosphorylation.

He LX. et al, (2023), Respiratory research, 24

Key Principles for Conducting a Good Randomized Controlled Trial.

Luo J., (2022), Respiratory care, 67, 1211 - 1213

Rethinking the efficacy of awake prone positioning in COVID-19-related acute hypoxaemic respiratory failure - Authors' reply.

Luo J. et al, (2022), The Lancet. Respiratory medicine, 10

Neuromedin U promotes human type 2 immune responses.

Ye Y. et al, (2022), Mucosal immunology, 15, 990 - 999

Pre-existing asthma as a comorbidity does not modify cytokine responses and severity of COVID-19

Luo J. et al, (2021), Allergy, Asthma & Clinical Immunology, 17

Identification of immune correlates of fatal outcomes in critically ill COVID-19 patients

Youngs J. et al, (2021), PLOS Pathogens, 17, e1009804 - e1009804

The Roles of Type 2 Cytotoxic T Cells in Inflammation, Tissue Remodeling, and Prostaglandin (PG) D2 Production Are Attenuated by PGD2 Receptor 2 Antagonism

Chen W. et al, (2021), The Journal of Immunology, 206, 2714 - 2724

Early prediction of extubation failure in patients with severe pneumonia: a retrospective cohort study.

Yu H. et al, (2020), Bioscience reports, 40

Efficacy of High-Flow Nasal Cannula vs Standard Oxygen Therapy or Nasal Continuous Positive Airway Pressure in Children with Respiratory Distress: A Meta-Analysis.

Luo J. et al, (2019), The Journal of pediatrics, 215, 199 - 208.e8

Resistance to apoptosis underpins the corticosteroid insensitivity of group 2 innate lymphoid cells.

Luo J. et al, (2019), The Journal of allergy and clinical immunology, 144, 1722 - 1726.e10

Fevipiprant, a selective prostaglandin D2 receptor 2 antagonist, inhibits human group 2 innate lymphoid cell aggregation and function.

Hardman C. et al, (2019), The Journal of allergy and clinical immunology, 143, 2329 - 2333

Load More